» Articles » PMID: 35098434

MiRNA Signatures in Diabetic Retinopathy and Nephropathy: Delineating Underlying Mechanisms

Overview
Specialties Biochemistry
Physiology
Date 2022 Jan 31
PMID 35098434
Authors
Affiliations
Soon will be listed here.
Abstract

A worldwide failure to achieve glycemic targets has led to complications associated with diabetes mellitus. In addition to genetic and other risk factors, epigenetic factors like DNA methylation, histone modifications, and non-coding RNAs play a significant part in the pathogenesis of complications. Among non-coding RNAs, miRNAs have been explored extensively since they control various biological processes. Their dysregulation has been implicated in various diseases including diabetic complications. Diabetic retinopathy and nephropathy are two common microvascular diabetic complications. Diabetic retinopathy affects the retina of the eye whereas nephropathy damages kidneys on account of prolonged hyperglycemia. This review aims to evaluate the role of miRNAs in diabetic retinopathy and diabetic nephropathy with an emphasis on the dysregulation of various pathways involved. In addition, the role of significant miRNAs as biomarkers for the diagnosis and prognosis of complications has also been discussed. Further, an update on the role of important miRNAs as potential therapeutic modalities has been given.

Citing Articles

New Insights on the miRNA Role in Diabetic Tendinopathy: Adipose-Derived Mesenchymal Stem Cell Conditioned Medium as a Potential Innovative Epigenetic-Based Therapy for Tendon Healing.

Russo M, Lepre C, Conza G, Tangredi N, DAmico G, Braile A Biomolecules. 2025; 15(2).

PMID: 40001567 PMC: 11852990. DOI: 10.3390/biom15020264.


Lysine acetylation and its role in the pathophysiology of acute pancreatitis.

Li X, Li X, Jinfeng Z, Yu T, Zhang B, Yang Y Inflamm Res. 2025; 74(1):13.

PMID: 39775049 DOI: 10.1007/s00011-024-01989-z.


Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis.

Al-Tantawy S, Eraky S, Eissa L Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39702603 DOI: 10.1007/s00210-024-03669-5.


Possible Role of Endothelial-Derived Cellular and Exosomal-miRNAs in Lipid-Mediated Diabetic Retinopathy: Microarray Studies.

Elmasry K, Habib S, Helwa I, Khaled M, Ibrahim A, Tawfik A Cells. 2024; 13(22).

PMID: 39594634 PMC: 11592818. DOI: 10.3390/cells13221886.


The emerging modulators of non-coding RNAs in diabetic wound healing.

Aghayants S, Zhu J, Yu J, Tao R, Li S, Zhou S Front Endocrinol (Lausanne). 2024; 15:1465975.

PMID: 39439564 PMC: 11493653. DOI: 10.3389/fendo.2024.1465975.


References
1.
Adamis A, Shima D, Yeo K, Yeo T, Brown L, Berse B . Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1993; 193(2):631-8. DOI: 10.1006/bbrc.1993.1671. View

2.
Adamis A, Berman A . Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008; 30(2):65-84. DOI: 10.1007/s00281-008-0111-x. View

3.
Al-Kharashi A . Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy. Saudi J Ophthalmol. 2018; 32(4):318-323. PMC: 6300752. DOI: 10.1016/j.sjopt.2018.05.002. View

4.
Amr K, Abdelmawgoud H, Ali Z, Shehata S, Raslan H . Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Br J Biomed Sci. 2018; 75(2):82-87. DOI: 10.1080/09674845.2017.1402404. View

5.
Barbacid M . The Trk family of neurotrophin receptors. J Neurobiol. 1994; 25(11):1386-403. DOI: 10.1002/neu.480251107. View